Loading...
XNASCOSM
Market cap15mUSD
Dec 31, Last price  
0.67USD
1D
0.07%
1Q
-11.10%
Jan 2017
-96.74%
IPO
-97.84%
Name

Cosmos Health Inc

Chart & Performance

D1W1MN
XNAS:COSM chart
P/E
—
P/S
0.29
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
86.37%
Rev. gr., 5y
7.56%
Revenues
53m
+6.02%
0000902,3697,639,022533,8026,755,43630,013,37837,083,88239,676,38555,406,33756,239,66750,347,65253,376,874
Net income
-19m
L+34.07%
-4,600-3,788,229-169,245-455246,5926,044,691-6,687,912-601,002-6,209,768-9,060,658-3,298,965820,786-7,961,649-13,830,371-18,542,654
CFO
-16m
L+5.15%
0-69,602-87,28931831,4006,525,625-497,089-2,126,081-8,760,141-1,555,306-4,788,842-11,501,718-7,097,174-14,870,639-15,635,999
Earnings
Aug 18, 2025

Profile

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
URL
https://www.cosmosholdingsinc.com/
IPO date
May 19, 2010
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
53,377
6.02%
50,348
-10.48%
Cost of revenue
74,594
57,633
Unusual Expense (Income)
NOPBT
(21,217)
(7,285)
NOPBT Margin
Operating Taxes
775
Tax Rate
NOPAT
(21,217)
(8,060)
Net income
(18,543)
34.07%
(13,830)
73.71%
Dividends
(32,005)
Dividend yield
364.00%
Proceeds from repurchase of equity
9,900
35,276
BB yield
-58.66%
-401.20%
Debt
Debt current
8,538
8,305
Long-term debt
5,048
4,844
Deferred revenue
(326)
Other long-term liabilities
1,764
2,913
Net debt
9,568
(20,169)
Cash flow
Cash from operating activities
(15,636)
(14,871)
CAPEX
(2,978)
(383)
Cash from investing activities
(13,760)
(21)
Cash from financing activities
12,694
35,048
FCF
(25,037)
(12,988)
Balance
Cash
3,853
20,765
Long term investments
166
12,554
Excess cash
1,350
30,801
Stockholders' equity
(92,048)
(66,982)
Invested Capital
142,279
121,125
ROIC
ROCE
EV
Common stock shares outstanding
11,969
1,928
Price
1.41
-69.08%
4.56
-94.59%
Market cap
16,876
91.94%
8,792
-84.11%
EV
26,443
(11,004)
EBITDA
(20,602)
(7,096)
EV/EBITDA
1.55
Interest
866
3,965
Interest/NOPBT